Clinical Trials, Availability & Alternatives
Retatrutide is investigational and not yet FDA-approved.
Short answer: No. Retatrutide is not commercially available anywhere in the world as of January 2026.
The only way to access retatrutide right now is through a clinical trial. Here's what you need to know:
| Trial | Phase | Focus | Status |
|---|---|---|---|
| TRIUMPH-1 | Phase 3 | Obesity | Enrolling |
| TRIUMPH-2 | Phase 3 | Obesity | Enrolling |
| TRIUMPH-3 | Phase 3 | Obesity | Enrolling |
| TRIUMPH-4 | Phase 3 | Obesity + Diabetes | Enrolling |
While waiting for retatrutide, several highly effective GLP-1 medications are available today:
Tirzepatide is a dual GLP-1/GIP agonist—it targets two of the three receptors that retatrutide does.
Compounded Tirzepatide
$297/month
Check EligibilityCompounded Semaglutide
$199/month
Check EligibilityBrand Options
$349+/month
Check Eligibility| If you want... | Choose... | Why |
|---|---|---|
| Maximum weight loss now | Tirzepatide | Closest results to retatrutide |
| Lowest cost | Compounded semaglutide | $199/month available |
| Most safety data | Brand Wegovy | Longest track record |
| Insurance coverage | Mounjaro (for diabetes) | Often covered for T2D |
You may see websites selling "retatrutide peptide" or "research grade retatrutide." Do not buy these products.
We're tracking retatrutide's development closely. Sign up for FDA approval announcements, commercial availability updates, and pricing information.
Don't wait for a hypothetical future drug. Tirzepatide is available today and produces similar results.
Compare Providers →Document your weight loss journey. This helps establish a baseline and shows your doctor what's working.
Sign up above for retatrutide updates. When it becomes available, you'll be among the first to know.